Skip to content
OpenCapital
Get started

Lennox International LII Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp

Segments

By product

See full
Equipment80%0.0%

Other financials

Income statement

See full
Revenue$1.1B+5.8%
Gross profit$351.3M+3.1%
Operating income$163.5M-2.7%
Net income$117.2M-9.6%
EPS (diluted)$3.35-7.7%

Balance sheet

See full
Cash & equivalents$48.2M-77.8%
Total debt$1.7B+7.6%
Total equity$1.2B+20.9%
Total assets$4.3B+24.2%

Cash flow

See full
Operating cash flow$16.1M+145%
CapEx$55.5M+118%
Free cash flow-$39.4M+35.7%

Valuation

See full
Market cap$18.83B-18.1%
Enterprise value$20.45B-16.6%
P/E23.7×-3.5×
P/S3.6×-0.7×

Profitability

See full
Gross margin33.2%+0.1pp
Operating margin19.7%+0.3pp
Net margin15.1%-0.1pp
FCF margin12.6%-1.8pp

Returns & leverage

See full
Return on equity75.8%-43.9pp
Debt / equity1.4×-0.2×
Current ratio1.6×+0.1×